No Data
Calculating The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)
Express News | Yoltech Therapeutics: Total Transaction Value Amounts to RMB 1.035 Bln, With Yoltech Receiving Tiered Royalties Based on Net Sales
Express News | Yoltech Therapeutics: Licensing Agreement With Salubris for Development & Commercialization of Yolt-101 in Mainland China
Shenzhen Salubris Pharmaceuticals' H1 Profit Up 2%, Operating Income Jumps 21%; Shares Rise 5%
Xinlitai: 2024 Semi-Annual Report Summary
Xinlitai: 2024 Semi-Annual Report
No Data
No Data